Brief: Orthocell Ltd Gets Regulatory Approval For Remplir Nerve Repair Device-OCC.Ax
21/03/2022 01:33
March 21 (Reuters) - Orthocell Ltd OCC.AX :
* REGULATORY APPROVAL FOR REMPLIR NERVE REPAIR DEVICE-OCC.AX
* ORTHOCELL RECEIVES AUSTRALIAN REGULATORY APPROVAL FOR
REMPLIR
FOR USE IN PERIPHERAL NERVE REPAIR PROCEDURES
Further company coverage: OCC.AX
Recent news on Orthocell
See all newsBrief: Orthocell Reports September Quarter Revenue Of A$3.6 Million
Australia's Orthocell rises as flagship product records first Thailand sales
Brief: Orthocell Says QTRLY A$3.2 Million Revenue Achieved
Australia's Orthocell set for best week since November 2024 on US DoD approval for key product
Brief: Orthocell's First Surgical Use Of Remplir In US Department Of Defense